spot_img

Former Pharma CEO said the quiet part out loud: “…PBMs are not the bandits here…the pharmaceutical industry charges higher prices in the U.S. than in other countries.”

Share This Post

Novo Nordisk’s outgoing CEO Lars Fruergaard Jørgensen has often argued that the company’s prices are dictated by middlemen – the so-called PBMs. But that explanation is a diversionary tactic, experts now say.

READ FULL ARTICLE

spot_img

Related Posts

Pfizer Issue Warning Over Birth Control Shot After Link to Brain Tumors

The U.S. Food and Drug Administration (FDA) has approved...

Why does big pharma pay doctors? It raises an important question about healthcare ethics

Transactions are happening outside public scrutiny. It’s galling to...

Prices for new US drugs doubled in 4 years

Median annual list price for new drugs over $370,000...

N.J. pharmaceutical company cuts 146 jobs after its drug was linked to deaths

A pharmaceutical company headquartered in New Jersey is shrinking...

Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025

Merck announced last week that it would acquire biotech...

CMS.GOV Reports Big Pharma & Medical Device Companies Paid Doctors $2.4 Billion In 2024 For: Travel, Meals, Entertainment, etc.

General Payments defined as: Food, travel, consulting, engagements, entertainment,...
- Advertisement -spot_img